December 27, 2012 at 10:05 AM EST
Keep an Eye on These Five New Drugs in the First Quarter of 2013
MINYANVILLE ORIGINAL Some drug and biotech companies including several industry leaders hope to win US approvals for potential blockbuster treatments during the first three months of 2013. The Food and Drug Administration will make a number of decisions in the first quarter regarding market clearance for experimental medicines. Here are five potential drug approvals scheduled for that period and the reason they’re key to strategies for the companies who developed the therapies. The descriptions are listed in chronological order. The date represents the deadline for the FDA to make a ruling on each drug. Some of these dates can ...
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here